BACKGROUNDAgreement • May 5th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 10(l) AMENDMENT #12 TO LOAN AGREEMENT DATED DECEMBER 1, 2001Loan Agreement • August 21st, 2002 • Lannett Co Inc • Pharmaceutical preparations
EXHIBIT 10 EMPLOYMENT AGREEMENT BETWEEN LANNETT COMPANY, INC. AND ARTHUR BEDROSIANEmployment Agreement • May 12th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 10(ag) Supply Agreement dated February 11, 1997*Supply Agreement • November 20th, 1998 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
LANNETT COMPANY, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 27, 2019 4.50% Convertible Senior Notes due 2026Indenture • September 27th, 2019 • Lannett Co Inc • Pharmaceutical preparations • New York
INDENTURE dated as of September 27, 2019 between Lannett Company, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), and Wilmington Trust, National Association, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
EXHIBIT 10.1Employment Agreement • March 21st, 2005 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
BACKGROUNDAgreement • October 25th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 10.1 EMPLOYMENT AGREEMENT BETWEEN LANNETT COMPANY, INC. AND ARTHUR BEDROSIAN This Employment Agreement ("Agreement") is entered into as of April 1, 2004 ("Effective Date") between Lannett Company, Inc. ("Company") and Arthur P. Bedrosian...Employment Agreement • October 25th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
LANNETT COMPANY, INC., as CompanyLannett Co Inc • December 2nd, 2015 • Pharmaceutical preparations • New York
INDENTURE, dated as of November 25, 2015, as amended or supplemented from time to time (this “Indenture”), among LANNETT COMPANY, INC., a Delaware corporation, the Subsidiary Guarantors from time to time parties hereto and WILMINGTON TRUST, NATIONAL ASSOCIATION, as trustee (in such capacity, the “Trustee”).
EXHIBIT 2.1 AGREEMENT DATED MARCH 23, 2004 BY AND BETWEEN LANNETT COMPANY, INC. AND JEROME STEVENS PHARMACEUTICALS, INC.Agreement • August 27th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 10.8Employment Agreement • September 13th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 26th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 22, 2021, by and among Lannett Company, Inc., a Delaware corporation (the “Company”), Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P. and BPC Lending II LLC, (each individually, a “Lender” and together, the “Lenders”).
3 REPRESENTATIONS AND WARRANTIES OF FARBERStock Purchase Option Agreement • June 14th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Delaware
RESTATED EMPLOYMENT AGREEMENT OF JOHN KOZLOWSKIEmployment Agreement • November 1st, 2017 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
This Restated Employment Agreement of John Kozlowski (“Agreement”) is entered into as of this 26th day of October, 2017 (“Effective Date”) between Lannett Company, Inc. (“Company”) and John Kozlowski (“Executive”).
EXHIBIT 10.9 AGREEMENT BETWEEN LANNETT COMPANY, INC. AND SIEGFRIED (USA), INC. DATED: October 31, 2002 Siegfried (USA), INC. of 33 Industrial Park Road, Pennsville, NJ 08070 ("Seller") will sell and LANNETT COMPANY INC. of Philadelphia, Pennsylvania...Lannett Co Inc • June 17th, 2004 • Pharmaceutical preparations • New Jersey
Exhibit 10(af) Philadelphia Authority for Industrial Development Tax-Exempt Variable Rate Demand/Fixed Revenue Bonds (Lannett Company, Inc. Project) Series of 1999 Exhibit 10 (af) Philadelphia Authority for Industrial Development Tax- Exempt Variable...Loan Agreement • September 28th, 1999 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 10(ag) Reinbursement Agreements supporting bond issuesReimbursement Agreement • September 28th, 1999 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 2nd, 2015 • Lannett Co Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 25, 2015, is entered into by and between Lannett Company, Inc., a Delaware corporation (the “Company”), and UCB Manufacturing, Inc., a Delaware corporation (“UCB”).
EXHIBIT 10.8 TERMS OF EMPLOYMENT AGREEMENT WITH LARRY DALESANDRO EFFECTIVE MAY 3, 2002 Should Lannett terminate your employment other than "for cause" (as defined below), you will be eligible for severance compensation in an amount to be determined by...Employment Agreement • October 25th, 2004 • Lannett Co Inc • Pharmaceutical preparations
Should Lannett terminate your employment other than "for cause" (as defined below), you will be eligible for severance compensation in an amount to be determined by Lannett, but not less than six (6) months of your base salary at the time of termination. You will also be eligible to continue your participation in the Company's medical benefit plans for six (6) months, at no cost to you. For purposes hereof, "for cause" is defined to include engaging in unethical business practices or conduct which creates a conflict of interest, fraud, malfeasance, criminal behavior, and willful conduct in violation of Lannett's Non-Harassment Policy or Corporate Handbook. If the Company is sold or a majority of the Company's ANDAs (Abbreviated New Drug Applications) are sold during your employment, and the Company or new organization terminates your employment, you will be eligible for severance compensation in an amount equal to one year of your current base salary at the time of termination. In this
EXHIBIT 10.9 AGREEMENT BETWEEN LANNETT COMPANY, INC. AND SIEGFRIED (USA), INC. DATED: October 31, 2002 Siegfried (USA), Inc. of 33 Industrial Park Road, Pennsville, NJ 08070 ("Seller") will sell and Lannett Company Inc. of Philadelphia, Pennsylvania...Lannett Co Inc • October 25th, 2004 • Pharmaceutical preparations • New Jersey
Siegfried (USA), Inc. of 33 Industrial Park Road, Pennsville, NJ 08070 ("Seller") will sell and Lannett Company Inc. of Philadelphia, Pennsylvania 19136 ("Buyer") will buy the Product on the terms and conditions contained herein. The terms of this Agreement and any signed addenda attached to this Agreement constitute the entire Agreement between the Seller and Buyer and supersede any existing sales contract relating to the Product. This Agreement must be signed and returned by Buyer within 30 days from the date first specified above and will not bind Seller unless signed by an authorized representative of Seller. The Agreement does not bind the Buyer unless it receives the Agreement signed by an authorized representative of the Seller on or before the date specified above. Subject to the terms and conditions of this Agreement, Seller shall sell to Buyer, and Buyer shall purchase exclusively from Seller, the Product
THIRD ADDENDUM to Employment Agreement of John AbtEmployment Agreement • January 20th, 2022 • Lannett Co Inc • Pharmaceutical preparations
This Third Addendum (the “Third Addendum”) to the Employment Agreement of John Abt is entered into as of this 17th day of January 2022, between Lannett Company, Inc. (the “Company”) and John Abt (“Mr. Abt”) (together, the Company and Mr. Abt shall be known as the “Parties”).
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT OF ARTHUR P. BEDROSIANEmployment Agreement • January 3rd, 2013 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
This Second Amended and Restated Employment Agreement of Arthur P. Bedrosian (“Agreement”) is entered into as of this 31st day of December, 2012 (“Effective Date”) between Lannett Company, Inc. (“Company”) and Arthur P. Bedrosian (“Executive”).
Exhibit 10(v) Amendment to Loan Agreement between the Company and Corestates Bank, dated May 23, 1997Loan Agreement • September 26th, 1997 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
FOR VALUE RECEIVED, each of the undersigned, jointly and severally if more than one (hereinafter collectively referred to as "Borrower"), promises to pay to the order of CoreStates Bank, N.A.*, a national banking association (the "Bank"), at any of its banking offices in Pennsylvania, the principal amount of
SECOND LIEN PLEDGE AND SECURITY AGREEMENT, dated as of April 22, 2021, among LANNETT COMPANY, INC., as the Borrower, each Guarantor from time to time party hereto, and ALTER DOMUS (US) LLC, as Administrative Agent and Collateral AgentPledge and Security Agreement • April 26th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
SECOND LIEN PLEDGE AND SECURITY AGREEMENT, dated as of April 22, 2021 (as amended, amended and restated, supplemented, waived or otherwise modified from time to time, this “Agreement”), among LANNETT COMPANY, INC., a Delaware corporation (as further defined in the Credit Agreement (as defined below), the “Borrower”), each Guarantor from time to time a party hereto, Alter Domus (US) LLC, as administrative agent (in such capacity and any successor in such capacity, the “Administrative Agent”) and Alter Domus (US) LLC, as collateral agent (in such capacity and any successor in such capacity, the “Collateral Agent”) for the Secured Parties (as defined below).
Lannett Company, Inc., as Company INDENTURE Dated as of April 22, 2021 Wilmington Trust, National Association, as Trustee and Note Collateral Agent PROVIDING FOR THE ISSUANCE OF NOTES IN SERIESIntercreditor Agreement • April 26th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of April 22, 2021, as amended or supplemented from time to time (this “Indenture”), among LANNETT COMPANY, INC., a Delaware corporation, the Subsidiary Guarantors from time to time parties hereto and WILMINGTON TRUST, NATIONAL ASSOCIATION, as trustee (in such capacity, the “Trustee”) and note collateral agent (in such capacity, the “Note Collateral Agent”).
Exhibit 10(w) Amendment to Loan Agreement between the Company and Corestates Bank, dated September 24, 1997Loan Agreement • September 26th, 1997 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
FOR VALUE RECEIVED, each of the undersigned, jointly and severally if more than one (hereinafter collectively referred to as "Borrower"), promises to pay to the order of CoreStates Bank, N.A.*, a national banking association (the "Bank"), at any of its banking offices in Pennsylvania, the principal amount of
EXHIBIT 10.1Separation Agreement and General Release • December 3rd, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 10.8Employment Agreement • October 25th, 2004 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
SUPPLY AGREEMENTSupply Agreement • November 20th, 1998 • Lannett Co Inc • Pharmaceutical preparations • Pennsylvania
AMENDMENT NUMBER ONE TO CREDIT AND GUARANTY AGREEMENT AND PLEDGE AND SECURITY AGREEMENTCredit and Guaranty Agreement • April 26th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
This CREDIT AND GUARANTY AGREEMENT, dated as of December 47, 2020, is entered into by and among LANNETT COMPANY, INC., a Delaware corporation (as further defined in Section 1.1, the “Parent Borrower”), the Subsidiary Borrowers from time to time party hereto (together with the Parent Borrower, jointly and severally, collectively, the “Borrowers” and each individually, a “Borrower”), CERTAIN SUBSIDIARIES OF THE PARENT BORROWER, as Guarantors, the Lenders party hereto from time to time, and WELLS FARGO BANK, NATIONAL ASSOCIATION (“WFB”) as Administrative Agent (together with its permitted successors in such capacity, “Administrative Agent”) and as Collateral Agent (together with its permitted successors in such capacity, “Collateral Agent”).
EXHIBIT 10.7 TERMS OF EMPLOYMENT AGREEMENT WITH ARTHUR BEDROSIAN EFFECTIVE JANUARY 25, 2002 Your salary for this position (Vice President of Business Development) will be paid at the rate of $2,980.77 per pay period (which is equivalent to an annual...Employment Agreement • October 25th, 2004 • Lannett Co Inc • Pharmaceutical preparations
Your salary for this position (Vice President of Business Development) will be paid at the rate of $2,980.77 per pay period (which is equivalent to an annual base salary of $155,000 per year), in accordance with the weekly payment schedule now being used by the Company. At the end of each calendar year, the Board of Directors, or its designee, may, in their sole discretion, award you a bonus based upon your individual performance and the Company's performance during the immediately preceding calendar year.
EXHIBIT 10.6 TERMS OF EMPLOYMENT AGREEMENT WITH KEVIN SMITH EFFECTIVE JANUARY 4, 2002 Your salary for this position (Vice President of Sales and Marketing) will be paid at the rate of $2,980.77 per pay period (which is equivalent to an annual base...Employment Agreement • June 17th, 2004 • Lannett Co Inc • Pharmaceutical preparations
Your salary for this position (Vice President of Sales and Marketing) will be paid at the rate of $2,980.77 per pay period (which is equivalent to an annual base salary of $155,000 per year), in accordance with the weekly payment schedule now being used by the Company. At the end of each calendar year, the Board of Directors, or its designee, may, in their sole discretion, award you a bonus based upon your individual performance and the Company's performance during the immediately preceding calendar year.
AMENDED AND RESTATED EXCHANGE AGREEMENTRegistration Rights Agreement • April 12th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED EXCHANGE AGREEMENT (this “Agreement”), dated as of April 8, 2021 (this “Agreement”), is entered into by and among Lannett Company, Inc., a corporation organized under the laws of Delaware (the “Borrower”), the BPC Funds (as defined herein), BPC Lending (as defined herein), Deerfield (as defined herein, and collectively with the BPC Funds and BPC Lending and together with their respective successors and assigns, each in such capacity a “Participating Lender”). Each of the Borrower and the Participating Lenders shall be referred to as a “Party” and, collectively, as the “Parties.”
SUPPLY AGREEMENTSupply Agreement • May 6th, 2021 • Lannett Co Inc • Pharmaceutical preparations • Hong Kong
THIS SUPPLY AGREEMENT (this “Agreement”) is made this 5th day of February 2021 (the “Effective Date”), by and among Sunshine Lake Pharma Co., Ltd., a corporation organized and existing under the laws of the People’s Republic of China, (“Seller”), and Lannett Company, Inc., a Delaware corporation (“Lannett”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.License and Supply Agreement • February 4th, 2021 • Lannett Co Inc • Pharmaceutical preparations • New York
This LICENSE AND SUPPLY AGREEMENT (“Agreement”), effective as of January 1, 2014 (the “Effective Date”) is by and between ALKERMES PHARMA IRELAND LIMITED, a limited liability company incorporated under the laws of Ireland (“Alkermes”). and KREMERS URBAN PHARMACEUTICALS INC., an Indiana corporation (“KU”).
